Polycomb genes and cancer: time for clinical application?

F Crea, E Paolicchi, VE Marquez, R Danesi - Critical reviews in oncology …, 2012 - Elsevier
Polycomb group genes (PcGs) are epigenetic effectors, essential for stem cell self-renewal
and pluripotency. Two main Polycomb repressive complexes (PRC1, PRC2) mediate gene …

Development and use of biomarkers in oncology drug development

E Floyd, TM Mcshane - Toxicologic pathology, 2004 - journals.sagepub.com
Successful development and use of biomarkers will improve the productivity of oncology
drug development. Recognition of the importance of biomarkers for speeding drug …

Molecular mechanisms of breast cancer progression: lessons from mouse mammary cancer models and gene expression profiling

Y Ye, TH Qiu, C Kavanaugh, JE Green - Breast disease, 2004 - content.iospress.com
The development of breast cancer is thought to occur through a multi-step process. The
majority of breast cancers likely develop over extended periods of time arising from early …

A microneedle array able to inject tens of thousands of cells simultaneously

GH Teichert, S Burnett, BD Jensen - Journal of Micromechanics …, 2013 - iopscience.iop.org
This paper presents a biological microelectromechanical system for injecting foreign
particles into thousands of cells simultaneously. The system inserts an array of microneedles …

Transgenic mouse models for the prevention of breast cancer

Q Shen, PH Brown - … Research/Fundamental and Molecular Mechanisms of …, 2005 - Elsevier
Breast cancer prevention research has made remarkable progress in the past decade. Much
of this progress has come from clinical trials. However, in the future to test the many …

Frontiers in cancer prevention research

AL Sabichi, MF Demierre, ET Hawk, CE Lerman… - Cancer research, 2003 - AACR
In October 2002, the AACR pioneered and hosted the first major annual meeting devoted to
cancer prevention. This signal event marked the rapid movement of cancer prevention to the …

Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography

CK Abbey, AD Borowsky, JP Gregg, RD Cardiff… - Journal of mammary …, 2006 - Springer
Small-animal imaging with positron emission tomography (PET) has become a valuable tool
for evaluating preclinical models of breast cancer and other diseases. In this review, we …

Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer.

KV Desai, CJ Kavanaugh, A Calvo… - Endocrine-related …, 2002 - erc.bioscientifica.com
Breast cancer is the most prevalent tumor in American woman. Multiple factors, including
age, diet, genetics, environment, geographic location, parity, as well as race, influence the …

Pathologic progression of mammary carcinomas in a C3 (1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer

MJ Hoenerhoff, MA Shibata, A Bode, JE Green - Transgenic research, 2011 - Springer
Abstract The C3 (1) component of the rat prostate steroid binding protein has been used to
target expression of the SV40 T/t-antigen to the mammary epithelium of mice resulting in pre …

Interrogating mouse mammary cancer models: insights from gene expression profiling

AA Fargiano, KV Desai, JE Green - Journal of mammary gland biology …, 2003 - Springer
Numerous mouse models for mammary cancer have been developed and characterized
based upon their biological, molecular, and histopathological features. In an effort to dissect …